This definition is problematic for at least two reasons: 1) the process of EMT involves at least partial loss of epithelial traits, and 2) it guarantees exclusion of additional circulating populations that are positive for both tumor markers and markers of other cell lineages from routine analyses (e.g., a CD45+ circulating hybrid cell (CHC) population). This evidence concerns the gene PTPRC and neoplasm.